After a sharp drop early in the COVID-19 pandemic, rates of routine breast and colon cancer screening soon returned to near-normal levels, a new study finds. “These are the first findings to show that, despite real fears about the consequences of drop-off in cancer screens, health facilities figured out how to pick this back up… read on > read on >



















